Literature DB >> 21054564

Detection of human papilloma virus in normal skin and in superficial and nodular basal cell carcinomas in immunocompetent subjects.

B Escutia1, E Ledesma, C Serra-Guillen, C Gimeno, J J Vilata, C Guillén, E Nagore.   

Abstract

BACKGROUND: Human papilloma virus (HPV) is increasingly recognized as an important human carcinogen but its role in the aetiopathogenesis of basal cell carcinoma (BCC) in immunocompetent individuals is unclear.
OBJECTIVE: A prospective case-control study was designed to compare the prevalence of HPV in BCC and normal skin samples from immunocompetent subjects and to assess the influence of different clinical features on the risk of cutaneous HPV.
METHODS: A total of 142 samples from 70 BCC cases (superficial BCC 38 and nodular BCC 32) and 72 controls were analysed by a degenerated nested PCR technique. Clinical data were recorded and risk factors for HPV infection were assessed by multivariate analysis.
RESULTS: There were 31 HPV DNA-positive samples. HPV was detected more frequently in cases (25.7%) than in controls (18.1%) and in nodular (31.3%) than in superficial (21.1%) BCC lesions but differences were not statistically significant. Older age (OR 1.5; 95% CI: 1.02-1.09) and actinic keratosis (OR 2.62; 95% CI 1.15-5.96) were the only significant factors associated to the presence of HPV. Risk of HPV positivity was also higher in blond-haired subjects, fair/pale skin colour, history of sunburn, solar lentigines and seborrheic keratosis but the differences were not significant. Both in cases and controls, β -types were the most frequent.
CONCLUSIONS: HPV does not seem to play a fundamental role in the aetiopathogenesis of either nodular or superficial BCC. The presence of HPV appears to be more related to actinic damage and possibly to an alteration of the barrier function associated with ageing.
© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2010        PMID: 21054564     DOI: 10.1111/j.1468-3083.2010.03875.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

1.  Low rate of detection of mucosal high-risk-type human papillomavirus in Korean patients with extragenital Bowen's disease and squamous cell carcinoma, especially in digital cases.

Authors:  Hye-Rim Park; Kwang Ho Kim; Soo Kee Min; Jinwon Seo; Dong Hoon Kim; Mi Jung Kwon
Journal:  Biomed Res Int       Date:  2013-08-19       Impact factor: 3.411

2.  Perianal Basal cell carcinoma.

Authors:  Isil Bulur; Emine Boyuk; Zeynep Nurhan Saracoglu; Deniz Arik
Journal:  Case Rep Dermatol       Date:  2015-02-21

3.  Detection of human papillomavirus infection by molecular tests and its relation to colonic polyps and colorectal cancer.

Authors:  Faten Gazzaz; Mahmoud H Mosli; Hani Jawa; Abdulrahman Sibiany
Journal:  Saudi Med J       Date:  2016-03       Impact factor: 1.484

4.  Incidence of betapapillomaviruses in the tumour and perilesional healthy skin in patients with basal cell carcinoma depending on sex, age, hair colour, tumour subtype, its location and dissemination.

Authors:  Katarzyna Sitarz; Jolanta Kopec; Slawa Szostek; Joanna Sulowicz
Journal:  Postepy Dermatol Alergol       Date:  2020-09-10       Impact factor: 1.837

5.  Eyebrow hairs from actinic keratosis patients harbor the highest number of cutaneous human papillomaviruses.

Authors:  Ines Schneider; Mandy D Lehmann; Vlada Kogosov; Eggert Stockfleth; Ingo Nindl
Journal:  BMC Infect Dis       Date:  2013-04-24       Impact factor: 3.090

6.  No Evidence of Human Papilloma Virus Infection in Basal Cell Carcinoma.

Authors:  Yalda Nahidi; Naser Tayyebi Meibodi; Zahra Meshkat; Habibollah Esmaili; Samaneh Jahanfakhr
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

7.  Natural history of cutaneous human papillomavirus (HPV) infection in men: the HIM study.

Authors:  Shalaka S Hampras; Anna R Giuliano; Hui-Yi Lin; Kate J Fisher; Martha E Abrahamsen; Bradley A Sirak; Michelle R Iannacone; Tarik Gheit; Massimo Tommasino; Dana E Rollison
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.